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Abstract: BACKGROUND First-pass myocardial perfusion cardiovascular magnetic resonance (CMR)
imaging yields high diagnostic accuracy for the detection of coronary artery disease (CAD). However,
standard 2D multislice CMR perfusion techniques provide only limited cardiac coverage, and hence con-
siderable assumptions are required to assess myocardial ischemic burden. The aim of this prospective
study was to assess the diagnostic performance of 3D myocardial perfusion CMR to detect function-
ally relevant CAD with fractional flow reserve (FFR) as a reference standard in a multicenter setting.
METHODS AND RESULTS A total of 155 patients with suspected CAD listed for coronary angiography
with FFR were prospectively enrolled from 5 European centers. 3D perfusion CMR was acquired on 3T
MR systems from a single vendor under adenosine stress and at rest. All CMR perfusion analyses were
performed in a central laboratory and blinded to all clinical data. One hundred fifty patients were suc-
cessfully examined (mean age 62.9±10 years, 45 female). The prevalence of CAD defined by FFR (<0.8)
was 56.7% (85 of 150 patients). The sensitivity and specificity of 3D perfusion CMR were 84.7% and
90.8% relative to the FFR reference. Comparison to quantitative coronary angiography (￿50%) yielded a
prevalence of 65.3%, sensitivity and specificity of 76.5% and 94.2%, respectively. CONCLUSIONS In this
multicenter study, 3D myocardial perfusion CMR proved highly diagnostic for the detection of significant
CAD as defined by FFR.
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1Myocardial perfusion imaging with cardiovascular mag-netic resonance (CMR) yields high diagnostic accuracy 
for the detection of coronary artery disease (CAD),1–8 and its 
prognostic value has also been documented.9–13 Standard two-
dimensional (2D) multislice perfusion CMR techniques have 
been compared with single photon emission computed tomog-
raphy in multicenter and single center trials,2,5,7,14,15 confirming 
the high diagnostic accuracy of CMR in prospective patient 
cohorts. Excellent diagnostic performance has been docu-
mented relative to hemodynamic measurements using frac-
tional flow reserve (FFR) at 1.5 T in a single center setting.16 
A potential limitation of standard 2D techniques, however, 
relates to the limited spatial coverage, which requires geomet-
ric assumptions for the quantification of ischemic tissue vol-
ume to guide therapy as recommended by the recent European 
guidelines on myocardial revascularization.17 Compared with 
methods that cover the whole heart, the acquisition of a lim-
ited number of slices may also affect the diagnostic perfor-
mance as has been indicated previously by comparing 3D 
versus simulated 3-slice 2D perfusion imaging.18
See Clinical Perspective
To address the limited, noncontiguous coverage of 2D mul-
tislice myocardial perfusion CMR techniques, three-dimensional 
(3D) methods have been developed based on recent advances in 
CMR scan acceleration methodology.19,20 Whole-heart coverage 
is achieved by using data undersampling strategies in conjunc-
tion with appropriate image reconstruction techniques,21 such 
as (k-t) imaging, including sensitivity encoding22–24 or principal 
component analysis.25 The diagnostic accuracy of 3D perfu-
sion CMR has recently been validated in single-center studies 
against both quantitative coronary angiography (QCA)18 and 
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FFR26 in patients with known or suspected CAD. Estimates of 
myocardial ischemic burden (MIB) from 3D perfusion CMR 
have also been shown to strongly correlate with those from 
single photon emission computed tomography.27 In addition, 
the high interstudy reproducibility of 3D myocardial perfusion 
CMR at 1.5 T has been shown in 2 different centers.28
The objective of the current study was to prospectively 
evaluate the diagnostic performance of dynamic whole-heart 
3D myocardial perfusion CMR at 3.0 T for the detection of 
significant CAD as defined by FFR in a multicenter setting.
Methods
Study Population
The present prospective study was conducted at 5 European centers 
(University Hospital Zurich, Switzerland; University Hospital RWTH 
Aachen, Germany; German Heart Institute Berlin, Germany; King’s 
College London, United Kingdom; University of Leeds, United 
Kingdom). The study was approved by the local ethics review boards 
and patients were prospectively enrolled upon written informed con-
sent. Patients scheduled for diagnostic coronary angiography for the 
evaluation of suspected CAD were consecutively recruited between 
November 2011 and August 2013. Patients were instructed to refrain 
from caffeine-containing substances 24 hours before the examination. 
Exclusion criteria were standard contraindications for CMR imaging 
(eg, incompatible metallic implants and claustrophobia) and adenos-
ine infusion (eg, high grade atrio-ventricular block and asthma).
Cardiovascular Magnetic Resonance Protocol
CMR imaging was performed with the patient in the supine position 
using 3.0 T MR systems (Philips Healthcare, Best, The Netherlands). 
Depending on the actual MR scanner version, either 6-element car-
diac or 28-element torso coil arrays were used for signal reception, 
and cardiac synchronization was performed using a vector ECG.
After the acquisition of standard cine scans for the assessment of 
left ventricular function, 3D myocardial perfusion CMR imaging 
was planned in short-axis geometry with full left-ventricular cover-
age. Adenosine was administered intravenously at a dose of 140 μg/
kg/min under continuous monitoring of heart rate and blood pres-
sure. After at least 3 minutes of adenosine infusion, stress first-pass 
perfusion imaging (i.v. bolus application of 0.075 mmol/kg b.w. of a 
gadolinium-based contrast agent, Gadovist, Bayer Healthcare, Berlin, 
Germany; injection rate 4.0 mL/s followed by 20 mL saline flush) 
was performed. After a 15-minute waiting period for equilibration 
of the contrast agent within the myocardium, the identical 3D myo-
cardial perfusion CMR scan was repeated at rest. Dynamic perfusion 
data were acquired in every heartbeat over 30 cardiac cycles with a 
3D saturation prepared spoiled turbo gradient echo sequence (repeti-
tion time/echo time/flip angle 1.8 ms/0.7 ms/15°, saturation prepulse 
delay 150 ms, acquisition timed to end-systole, 75% partial Fourier 
sampling in 2 directions, including an elliptical k-space shutter, 10× 
k-t acquisition with 49 training profiles resulting in a net acceleration 
of 7× and an acquisition window per heartbeat of 200 ms, k-t prin-
cipal component analysis reconstruction of 16 contiguous slices of 5 
mm thickness, acquired voxel size 2.3×2.3 mm2).20 Perfusion imaging 
was performed during a single inspiration breathhold. Shallow expi-
ration was permitted in case the inspiration breathhold could not be 
sustained during the scan. Using this approach, data acquisition in all 
patients suitable for CMR exams was possible.
After a further 15-minute waiting period, late gadolinium enhancement 
imaging (0.15 mmol/kg b.w. cumulative dose) was performed in the iden-
tical short-axis geometry with a 3D inversion prepared spoiled gradient 
echo sequence (repetition time/echo time/flip angle 3.6 ms/1.8 ms/15°, 
voxel size 1.6×1.6×10 mm3). The inversion recovery prepulse delay was 
determined using a Look-Locker sequence and adjusted accordingly.
Sample whole-heart 3D myocardial perfusion CMR images ac-
quired during adenosine stress and at rest are presented in Figure 1.
Visual Assessment of Perfusion Scans
CMR images were analyzed visually in a central data analysis lab-
oratory by reviewers blinded to clinical and angiographic patient 
data using a dedicated workstation (ExtendedWorkSpace, Philips 
Healthcare, Best, The Netherlands).
Overall image quality of stress and rest perfusion scans was grad-
ed on a scale between 1 and 4 (1=nondiagnostic, 2=poor, 3=good, 
Figure 1. Example whole-heart 3D cardiovascular 
magnetic resonance (CMR) perfusion data acquired 
during adenosine stress (A) and at rest (B). A perfu-
sion defect is seen in the anterior and anteroseptal 
segments extending from base to apex. Invasive 
X-ray angiography confirms a relevant stenosis of the 
ostial left anterior descending artery with fractional 
flow reserve (FFR) value of 0.53. The circumflex (C,D) 
and right coronary artery (E) had no stenosis.
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4=excellent). From all acquired image slices, the subset of short-axis 
slices with clearly identifiable left-ventricular cavity enhancement 
during contrast agent passage and with >75% circumferential left-
ventricular myocardium present were identified. The selected short-
axis slices were divided into 6 equally distributed circumferential 
segments each and evaluated visually. Perfusion defects on the stress 
perfusion images seen in any segment (≥1 segment) with ≥25% trans-
murality persisting for ≥3 consecutive dynamics, which were not vis-
ible in the rest perfusion scan and showed no enhancement in the late 
gadolinium enhancement scan, were marked to be pathological, and 
the overall study was considered as abnormal.
Assessment of Myocardial Ischemic Burden
MIB was estimated based on the quantification of the tissue volume 
exhibiting myocardial hypo-enhancement using dedicated software 
(GTVolume, GyroTools LLC, Zurich, Switzerland). For determina-
tion of myocardial hypo-enhancement, the dynamic frame of the 
stress perfusion scan showing the maximum extent of regional hypo-
enhancement during peak signal enhancement of remote myocar-
dium was selected.18 In the presence of extensive ischemia-related 
hypo-enhancement (eg, high grade triple vessel disease), remote 
myocardium either represented an entire myocardial segment or its 
subepicardial layer. The left ventricular endo- and epicardial borders 
were manually identified in all slices to determine myocardial vol-
ume. Quantification of hypo-enhanced tissue volume was performed 
automatically using threshold-based segmentation with a signal in-
tensity threshold >2× standard deviation below the signal of remote 
myocardium. Segmentation of myocardial hypo-enhancement during 
stress is illustrated in Figure 2 for the patient data shown in Figure 1.
Total volumes of left ventricular myocardium and hypo-enhanced 
myocardium were calculated using the disk summation method. MIB 
was defined by the volume of hypo-enhancement normalized to to-
tal left ventricular myocardial volume and is quoted in percentage. 
In case of concurrent presence of myocardial scar as identified on 
late gadolinium enhancement images, the amount of scar tissue vol-
ume was calculated based on segmentation of hyperintense tissue. 
Subsequently, the scar tissue volume was subtracted from the volume 
of hypo-enhancement before MIB calculation.
Fractional Flow Reserve and Quantitative Coronary 
Angiography Measurements
FFR was measured using standard methods29 with a 0.014-inch coro-
nary pressure sensor–tip wire (Volcano Therapeutics, San Diego, 
California or Pressure-Wire Certus, St. Jude Medical Systems AB, 
Uppsala, Sweden) in vessels visually assessed by the angiographers 
as having ≥50% and ≤80% diameter stenosis in 2 orthogonal views 
with ≥2 mm luminal diameter. For the purpose of the study and in 
accordance to guidelines, stenoses in vessels with <2 mm luminal 
diameter were considered nonsignificant.30 Coronary stenosis with an 
FFR value <0.8 were classified as hemodynamically relevant. Total/
subtotal occlusion or high-grade stenosis (>80% diameter stenosis) 
did not undergo pressure wire assessment and were considered he-
modynamically significant.
Coronary angiography was performed by routine techniques. At 
least 2 orthogonal views of every major coronary vessel and its side 
branches were acquired. QCA was performed offline by an indepen-
dent core laboratory being blinded to the results of CMR imaging.
Statistical Analysis
Data analysis was performed using SPSS for Windows 17.0.0 (SPSS 
Inc., Chicago, IL). Data were evaluated on a patient basis to deter-
mine sensitivity, specificity, negative and positive predictive values 
with corresponding 95% confidence intervals (95% CI) accord-
ing to standard definitions. Continuous variables are expressed as 
mean±standard deviation; categorical variables are expressed as pro-
portions. The paired Student’s t test was used to assess the statistical 
significance of continuous variables between rest and stress. All tests 
were 2-tailed; P<0.05 was considered significant. Receiver–operator 
characteristic curve analysis was used to determine the diagnostic ac-
curacy (area under curve) and optimal cut-off value of MIB to detect 
significant CAD defined by FFR <0.8.
Cohen’s kappa analysis was applied to compare 3D myocardial 
perfusion cardiovascular MRI outcome versus FFR outcome using 
the following grading: 0 to 0.2 (poor), 0.21 to 0.4 (fair), 0.41 to 0.6 
(moderate), 0.61 to 0.8 (substantial), and 0.81 to 1.0 (nearly perfect).
Results
Patient Characteristics
The characteristics of the patient cohort are listed in Table 1. 
Of the 155 recruited patients, 2 studies were lost because 
of data storage failure, 1 study was incomplete because of 
patient claustrophobia, 1 study had to be terminated because 
of a bronchospasm during adenosine infusion and 1 study was 
incomplete because of an unknown ferromagnetic splint in the 
chest wall. Accordingly, a total of 150 patients (n=30 from 
Zurich, n=30 from Aachen, n=32 from Berlin, n=31 from 
London, and n=27 from Leeds; n=105 (70%) male; mean age 
62.9±10.0 years, range 33–83 years) formed the final popula-
tion for analysis. Table 2 lists the hemodynamic data recorded 
during the CMR examination.
Diagnostic Performance
The prevalence of CAD as defined by FFR <0.8 was 56.7% 
(85 of 150 patients) and the sensitivity of 3D perfusion CMR 
was 84.7% (95% CI 75.3–91.6) with a specificity of 90.8% 
(95% CI 81.0–96.5) and diagnostic accuracy of 87.3% (95% 
CI 81.1–91.7). Positive and negative predictive values were 
92.3% (95% CI 84.0–97.1) and 81.9% (95% CI 71.1–90.0), 
respectively.
When analyzed per vessel territory (387 of 450 territo-
ries), sensitivity was 73.5% (95% CI 63.9–81.8), specificity 
was 91.9% (95% CI 88.1–94.8), and diagnostic accuracy was 
87.1% (95% CI 83.4–90.1). The positive predictive value was 
76.5% (95% CI 66.9–84.5) and the negative predictive value 
was 90.7% (95% CI 86.7–93.8).
Cohen’s kappa showed substantial agreement of perfu-
sion imaging outcome and FFR outcome on a per-patient 
Figure 2. Segmentation of myocardial hypo-enhancement dur-
ing stress for the patient data shown in Figure 1. The volume of 
myocardial hypo-enhancement normalized to the left ventricular 
volume is 37%.
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and per-vessel territory analysis (kappa value 0.75 and 0.66, 
respectively).
The prevalence of CAD as defined by QCA ≥50% was 
65.3% (98 of 150 patients). Analysis of 3D CMR perfusion 
data with QCA as the reference standard yielded a sensitivity 
of 76.5% (95% CI 66.9–84.5), specificity of 94.2% (95% 
CI 84.0–98.7), and diagnostic accuracy of 82.6% (95% CI 
75.8–87.9). The positive predictive value was 96.2% (95% CI 
89.2–99.2) and the negative predictive value was 68.1% (95% 
CI 56.0–78.55).
Analysis per vessel territory relative to QCA (450 of 450 
territories) yielded a sensitivity of 61.5% (95% CI 53.9–68.6), 
specificity of 91.5% (95% CI 87.5–94.5), and diagnostic accu-
racy of 79.6% (95% CI 75.6–83.0). The positive predictive 
value was 82.7% (95% CI 75.2–88.7) and the negative predic-
tive value was 78.2% (95% CI 72.3–82.7).
Myocardial Ischemic Burden
The mean MIB in all patients was 10.1%±12.2% (range, 0%–
51.7%). The mean MIB in patients grouped by FFR status is 
given in Figure 3.
The diagnostic accuracy of MIB to detect significant CAD 
as defined by FFR was 0.91, and the optimal MIB cut-off 
value was 4.1%, which resulted in a sensitivity and specificity 
of 84.7% (95% CI 75.3–91.6) and 92.3% (95% CI 82.9–97.3), 
respectively (Figure 4).
Image Quality
The 3D CMR stress and rest perfusion scans of all 150 patients 
were of diagnostic image quality (image quality score ≥2). 
The mean visual scores of 3D stress and rest CMR perfusion 
scans were 3.57±0.58 and 3.65±0.51, respectively.
Discussion
The present multicenter study has assessed the diagnostic per-
formance of whole-heart 3D myocardial perfusion CMR for 
the detection of significant CAD as determined by FFR and 
QCA. The main findings of the study are (1) 3D myocardial 
perfusion CMR at 3.0 T is a robust technique for the detection 
of CAD in a European multicenter, single-vendor setting; (2) 
the diagnostic accuracy of 3D myocardial perfusion CMR to 
detect functionally significant CAD is high and confirms pre-
vious data on 2D multislice and 3D whole-heart myocardial 
Table 2. Hemodynamic Parameters
Parameter n=150
Heart rate, bpm
  At rest 65.5±12.5
  Adenosine stress 83.2±15.4*
Systolic blood pressure, mm Hg
  At rest 129±21
  Adenosine stress 127±21
Diastolic blood pressure, mm Hg
  At rest 73±10
  Adenosine stress 71±10†
Data are presented as mean±SD.
*P<0.0001.
†P<0.05 for rest vs stress (paired Student’s t test).
Figure 3. Myocardial ischemic burden (MIB) of the study popula-
tion given as mean values and corresponding 95% confidence 
intervals as a function of hemodynamic stenosis significance as 
defined by fractional flow reserve (FFR). Differences between 
groups are statistically significant (P<0.001).
Table 1. Patient Demographics and Clinical Data
Parameter n=150
Male, n (%) 105 (70)
Age, y 62.9±10.0
Age range 33–83
BMI, kg/m² 27.8±4.3
Cardiovascular risk factors, n (%)
  Arterial hypertension 109 (73)
  Diabetes mellitus 27 (18)
  Hyperlipidemia 100 (67)
  Smoking 73 (49)
  Family history of CAD 55 (37)
Medication, n (%)
  β-Blocker 76 (51)
  ACE inhibitor 71 (47)
  Statin 91 (61)
  Nitrates 14 (9)
  Diuretics 33 (22)
  ARBs 24 (16)
  Ca antagonist 27 (18)
  Aspirin 112 (75)
Coronary artery disease, n (%)
  Single-vessel disease 41 (27)
 Multi-vessel disease 57 (38)
Left ventricular function
  LVEF (%) 62.1±7.2
  LVEDV (mL) 132±36
  LVESV (mL) 51±22
Data are presented as n (%) or mean±SD. ACE indicates angiotensin-
converting enzyme; ARB, angiotensin-II receptor blocker; BMI, body mass index; 
CAD, coronary artery disease; LVEF, left ventricular ejection fraction; LVEDV, left 
ventricular end-diastolic volume; and LVESV, left ventricular end-systolic volume.
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perfusion CMR using FFR as the reference standard16,26,28,31,32; 
and (3) the MIB derived from 3D whole-heart myocardial 
perfusion CMR provides an accurate diagnostic tool for the 
detection of flow-limiting CAD.
Relative to previous single-center (3T CMR) and dual-
center (1.5T CMR) 3D CMR perfusion studies using FFR 
as a reference, our results compare well for sensitivity and 
specificity (85% versus 91%26 versus 90%28 and 91% versus 
90%26 versus 82%28), demonstrating robustness of the method 
also in a European multicenter setting. The added benefit of 
3D myocardial perfusion CMR over 2D three-slice imaging 
for assessing MIB has recently been indicated.27 Furthermore, 
the high interstudy, intra- and inter-reader reproducibility has 
been confirmed.18,28 Although the present multicenter study 
was conducted using 3.0 T CMR systems, the protocol is read-
ily applicable to 1.5 T machines as demonstrated previously.28 
Application of the method on MR systems from different ven-
dors is possible upon modification of the pulse sequence and 
image reconstruction software. To this end, the image recon-
struction code is provided on request.
Although previous single-center validation of 3-slice 2D 
approaches using 1.5 T CMR systems yielded similarly high 
sensitivity and specificity relative to FFR,16 the assessment 
of ischemic tissue volume was not possible given the limited 
coverage of 2D methods. As demonstrated previously, the 
diagnostic performance of 3D perfusion imaging compares 
favorably against simulated 3-slice data extracted from the 3D 
volume.18,26
According to current guidelines, the decision to perform 
coronary revascularization procedures should be based on an 
objective documentation of myocardial ischemia preferably 
together with its anatomic localization and amount.17
Based on current and previous studies, 3D myocardial 
perfusion CMR may prove a valuable alternative to methods 
using ionizing radiation to monitor and guide treatment. CMR 
also allows imaging of at least the proximal coronary anat-
omy and fusion of 3D CMR perfusion with coronary CMR 
or low-dose coronary computed tomography angiography 
(CCTA) offering promise for future comprehensive noninva-
sive assessment of CAD.33
The amount of myocardial ischemia is a key factor to guide 
treatment decisions, that is, revascularization is recommended 
in case MIB exceeds 10%30 of total left ventricular myo-
cardium. However, these cut-off values were derived from 
nuclear studies34,35 and, although never directly compared, 
may not apply to 2D perfusion CMR in view of its limited car-
diac coverage. Three-dimensional myocardial perfusion CMR 
and single photon emission computed tomography agree well 
with the 10% threshold,27 highlighting another potential ben-
efit of 3D whole-heart versus 2D multislice myocardial perfu-
sion CMR.
Today, the invasive assessment of the functional significance 
of coronary lesions is the basis of therapeutic decision-mak-
ing,36,37 even though FFR measurements are invasive, time-
consuming, and associated with radiation exposure rendering 
the method less attractive for monitoring patients. To this end 
and based on the evidence presented here and elsewhere, 3D 
myocardial perfusion CMR may be considered a noninvasive 
alternative to stratify patients according to guidelines.
Study Limitations
An important limitation of the study design is that only 
patients who were already scheduled for a coronary angio-
gram were recruited in the study. This fact reflects the current 
practice of referral by external physicians. In line with current 
guidelines and to minimize complications of FFR measure-
ments, hemodynamic assessments were only performed in 
vessels with luminal stenosis of 50% to 80% at angiography. 
In addition, the assessment of MIB was given as percentage 
ischemic myocardium, reflecting only relative myocardial 
perfusion distribution at one particular time point during the 
dynamic first-pass of the contrast agent. Accordingly, MIB is 
not a direct measure of quantitative myocardial blood flow. It 
is furthermore acknowledged that all CMR centers involved in 
our study are specialized in CMR imaging, and it remains to 
be demonstrated how the technique performs at sites with less 
experience and expertise.
Conclusions
This multicenter study has demonstrated the robustness and 
accuracy of 3D myocardial perfusion CMR to detect function-
ally significant CAD as measured by FFR.
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CLINICAL PERSPECTIVE
Cardiovascular MRI (CMR) is increasingly established as an important method for the diagnosis of cardiovascular disease. 
First-pass myocardial perfusion CMR imaging yields high diagnostic accuracy for the detection of coronary artery disease. 
However, standard 2D multislice CMR perfusion techniques provide only limited cardiac coverage and hence considerable 
assumptions are required to assess myocardial ischemic burden. To address the limited coverage of 2D multislice myocardial 
perfusion CMR techniques, three-dimensional (3D) methods have been developed based on recent advances in CMR scan 
acceleration methodology. Using a multicenter setting, dynamic 3D-CMR stress perfusion imaging is shown to provide high 
diagnostic accuracy and allows quantification of the percentage of ischemic myocardium by direct volumetry. Because mea-
surements of ischemic burden are increasingly used to guide decision-making regarding the need for revascularization with 
>10% ischemic burden, 3D-CMR perfusion imaging is expected to play an important role as a noninvasive and radiation-free 
method for stratifying patients with stable coronary artery disease.
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